Proprotein Convertase Subtilisin Kexin Type 9, PCSK9, lipoprotein, lipoprotein particles, homeostasis LDL receptor, LDLR, Evolocumab, Therapeutic antibody, TDM, drug monitoring
B-TeZ PCSK9 Neutralization Rate/Evolocumab Kit (RPE), 96 Well
NEW

B-TeZ PCSK9 Neutralization Rate/Evolocumab Kit (RPE), 96 Well

Product No.:
R777
ca. 3-4 days ca. 3-4 days (abroad may vary)
Antigen:
free PCSK9 and free Evolocumab
590,00 EUR

plus 19% tax